Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for 24-Hour Continuous Sedation in Pre-Eclamptic Women
NCT07021521Completed
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of midazolam in anxiety disorder, sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoint: Visual Analog Anxiety Rating Scale at 24 hours. Started Apr 2021; status: completed.
02
Drugs
midazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07021521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07021521.